Stay updated on SG + Pembrolizumab in HR+ / HER2- MBC Clinical Trial
Sign up to get notified when there's something new on the SG + Pembrolizumab in HR+ / HER2- MBC Clinical Trial page.

Latest updates to the SG + Pembrolizumab in HR+ / HER2- MBC Clinical Trial page
- ChecktodayChange DetectedThe revision label was updated from v3.6.2 to v3.6.3, signaling a version update for the page.SummaryDifference0.0%

- Check8 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, indicating a newer build of the page. This update affects only the versioning metadata displayed on the page and does not modify the study content.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page adds a recruitment status line ('No longer looking for participants') and new help sections (How to Read a Study Record, Common Questions, How to Join a Study), and it also updates the Intervention/Treatment header formatting along with the revision label to v3.6.0, reflecting a mix of usability improvements and cosmetic/version changes.SummaryDifference0.4%

- Check29 days agoChange DetectedThe page's revision tag was updated to reflect a newer internal version. This indicates a small update to the page rather than a change to study details or user-facing content.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision tag updated to v3.5.4, reflecting a new release of the page content. This indicates the page was republished or deployed with changes.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page’s footer revision label was updated from **Revision: v3.5.2** to **Revision: v3.5.3**.SummaryDifference0.0%

Stay in the know with updates to SG + Pembrolizumab in HR+ / HER2- MBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SG + Pembrolizumab in HR+ / HER2- MBC Clinical Trial page.